Dare (DARE) Up in Active Trading for June 23

Equities Staff  |

Dare Bioscience Inc (NASDAQ:DARE) shares moved 5.65% today on 1,139,694 shares - in comparison to their 30 day average of 865,055 shares traded.

With today’s closing at $1.31 the company has a 50 day moving average of $1.17.

The company anticipates its next earnings on 2022-08-11.

Dare is down 38.00% so far this year.

For technical charts, analysis, and more on Dare visit the company profile.

About Dare Bioscience Inc

Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

To get more information on Dare Bioscience Inc and to follow the company's latest updates, you can visit the company's profile page here: Dare Bioscience Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Will Mining Stocks Fall Further?
3 Reasons To Be Optimistic About the Global Shipping Industry
The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks

Market Movers

Sponsored Financial Content